NCT07215403View on ClinicalTrials.gov

Prescriptive Infusion Algorithm (PIA)

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

May 1, 2026

Primary Completion Date

December 30, 2027

Study Completion Date

March 1, 2028

Conditions

PARKINSON DISEASE (Disorder)

Interventions

PROCEDURE

Prescriptive Infusion Algorithm

The study intervention is comprised of the neurosurgical procedure and the bilateral intraputaminal delivery of AB-1005.

DRUG

AB-1005

bilateral intraputaminal delivery of AB-1005

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

AskBio Inc

INDUSTRY